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Abstract
Background—Racial disparities in care and outcomes contribute to mortality and morbidity in 
children however the role in pediatric Crohn’s disease (CD) is unclear. In this study, we compared 
cohorts of Black and White children with CD to determine the extent race is associated with 
differences in readmissions, complications, and procedures among hospitalizations in the United 
States.
Methods—Data were extracted from the Pediatric Health Information System (January 1, 2004–
June 30, 2012) for patients ≤21 years of age hospitalized with a diagnosis of CD. White and Black 
cohorts were randomly selected in a 2:1 ratio by hospital. The primary outcome was time from 
index hospital discharge to readmission. The most frequent complications and procedures were 
evaluated by race.
Results—There were 4377 patients. Black children had a shorter time to first readmission and 
higher probability of readmission (p=0.009), and a 16% increase in risk of readmission compared 
to White children (p=0.01). Black children had longer length of stay and higher frequency of 
overall and late (30 days–12 months post discharge) readmissions (p<0.001). During index 
hospitalization, more Black children had perianal disease and anemia (p<0.001). During any 
hospitalization, Black children had higher incidence of perianal disease, anemia, and vitamin D 
deficiency, and greater number of perianal procedures, endoscopies, and blood product transfusion 
(p<0.001).
Conclusions—There are differences in hospital readmissions, complications, and procedures 
among hospitalized children related to race. It is unclear whether these differences are due to 
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genetic differences, worse intrinsic disease, adherence, access to treatment, or treatment 
disparities.
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INTRODUCTION
Inflammatory bowel disease (IBD), which includes Crohn’s disease (CD) and ulcerative 
colitis (UC), is a chronic, relapsing, inflammatory disorder that primarily affects the 
digestive tract of approximately 1.4 million people in North America,1, 2 with 25% being 
diagnosed in childhood. IBD carries a significant burden of disease given its rising 
incidence,3–5 the significant associated morbidity, psychosocial effects6–8 and the healthcare 
related costs9–11.
Disparities in care and outcomes contribute to mortality and morbidity in various conditions 
in children including asthma, congenital heart disease, diabetes, and ADHD.12–19 The 
Institute of Medicine defines a disparity as “racial or ethnic difference in the quality of 
healthcare that is not due to access-related factors or clinical needs, preference and 
appropriateness of intervention”.20
Health disparity research in adult IBD and other disease processes suggest that minority 
status, female gender and low socioeconomic status are related to poorer outcomes.21, 22 
There are numerous differences between Black and White IBD patients in regards to health 
care utilization practices and disease impact upon daily activities,23 as well as evidence of 
racial differences regarding characteristics of IBD, including more severe disease among 
minority patients.24, 25 Disproportionately high rates of IBD-related hospitalizations and 
mortality among non-Hispanic Blacks as compared to non-Hispanic Whites occur, even 
after taking into account differences in IBD prevalence across racial groups.26 Bowel 
resection among hospitalized adult CD patients varies by race, health insurance status and 
gender.27 A systematic review of 40 studies reported evidence for race and SES-based 
disparities in IBD care, especially with regard to surgical care and in-hospital mortality 
risk.28
We suspect healthcare disparities also exist in pediatric IBD, which may contribute to 
variation in care, increased costs and poorer outcomes, however data in children is limited. 
The effects of race on hospital admissions in children with CD are unknown. Our study 
begins to address this gap by evaluating racial differences between Black children and White 
children with CD who are hospitalized. The main objectives of our study were to determine 
1.) if Black children hospitalized for CD are more likely to be readmitted and have longer 
length of stay (LOS) compared to White children 2.) if corticosteroids, biologic agents and 
total parenteral nutrition (TPN) usage differs between races and 3.) if there are differences in 
CD related complications and procedures between races.
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The Pediatric Health Information System (PHIS) database is a large, administrative database 
established in 2002 (with archived data since 1992) by Children’s Hospital Association 
(formerly known as Child Health Corporation of America). PHIS contains comprehensive 
inpatient data from 44 not-for-profit children’s hospitals in the United States, which 
represents about 25% of pediatric centers in the U.S. and the majority of the tertiary care 
centers.
PHIS provides direct access to the data and viewers can select which hospitals and networks 
to compare. Encrypted medical record numbers (MRN) allow longitudinal tracking of 
patients over time within an institution. Standardized data is collected on demographics, 
diagnoses, procedures, interventions, outcomes and resource utilization for all pediatric 
patients admitted to participating hospitals. Data elements are abstracted and coded using 
PHIS data quality guidelines (de-identified at submission and reliability/validity checks are 
performed before database inclusion).
Study Cohort
The study population included pediatric patients (age ≤21years) who were admitted to a 
PHIS affiliated hospital between January 1, 2004 and June 30, 2012. Patients entered the 
study cohort on the day of admission of their index hospitalization (first hospitalization in 
the study period) and were followed through subsequent admissions during the entire study 
period. Patients were included in the study population if they had a primary or secondary 
diagnosis of CD (555.×) and if both race and gender were reported. A hospitalization was 
excluded if a patient was admitted and discharged on the same day, or if a patient was 
admitted for an ostomy take down (CPT 44625, ICD 9 procedure code 46.5×) as this 
procedure was considered an elective, planned admission. Other exclusion criteria included: 
missing race, multiple races, Hispanic ethnicity, missing gender, or gender mismatch among 
two or more encounters. A subset of eligible patients was randomly selected at the hospital 
level to achieve a 2:1 ratio of Whites to Blacks which increased the number of patients in the 
study (relative to parity). Whereas some hospital sites had more Whites than Blacks, a few 
sites had a disproportionately higher number of Blacks due to their local population 
demographics. In order to maintain this ratio at each hospital site, the number of Blacks was 
reduced using random selection at a given site where the number of Whites was less than 
twice the number of Blacks. No matching based on potentially confounding variables was 
performed; rather, the influence of potential confounds was controlled for statistically.
Variables
Basic demographics included: gender, age, race, ethnicity, payor, median neighborhood 
income, and hospital location. We included only patients who reported a single race for 
analysis. Payor status was assigned to 1 of 3 groups: commercial insurance, Medicaid, or 
other (APPENDIX A). Additional variables collected included admission and discharge 
dates, discharge ID, MRN (encrypted), LOS, and number of readmissions.
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Secondary predictors included payor status, and median neighborhood income. Regional 
divisions (Northeast, South, Midwest, and West) were derived from the state in which the 
hospital resided and then assigned to a region based on the 2010 Census Regions and 
Divisions of the United States (www.census.gov). The median neighborhood incomes were 
based upon patients’ actual zip code at initial hospitalization.
Treatment variables included corticosteroids, biologic agents and TPN use. We collected the 
number of IBD-related complications and abdominal surgical procedures during the index 
hospitalization by generating a list of the top 200 procedural codes and complications in the 
study cohort and grouped them along clinical grounds. (APPENDIX B)
Outcomes
The primary outcome was the time from index hospital discharge to readmission as it was 
more indicative of poor post-hospitalization care and/or poor self-management. We also felt 
an admitted population would increase the likelihood of similar disease severity between 
groups at study entry (i.e. both cohorts demonstrated significant enough disease to warrant 
hospitalization) and assure that the patient had established care within a pediatric medical 
center, although admission criteria vary and several factors could potentially affect the 
decision to admit a patient, (e.g., access to care, reliability of follow-up, etc.). Readmissions 
were divided into 2 categories: early (< 30 days from initial discharge) and late (30 days to 1 
year after initial discharge). Secondary outcomes included median LOS and the number of 
readmissions. Secondary predictors included payor status and the median neighborhood 
income associated with zip code.
Study Design
This is a retrospective review of patients who were hospitalized with a diagnosis of CD. To 
assess the validity of the data extracted from PHIS, a subset of the main cohort was created, 
consisting of 113 CD patients (37 Black and 76 White) from Nationwide Children's Hospital 
(NCH). Chart reviews were conducted for this group, and the results were compared to the 
data extracted from PHIS. Variables examined included: race, CD diagnosis, payor status, 
and corticosteroids, biologic agents (infliximab, adalimumab, and certolizumab), and TPN.
Statistical Analyses
To examine the validity of data extracted from PHIS, percent agreement was calculated 
between PHI data and the corresponding data obtained via medical record review at NCH. 
Baseline and demographic characteristics were summarized using standard descriptive 
statistics. Effect sizes were calculated using Cohen’s d to describe the magnitude of the 
difference between races. Categorical data were compared between races using either the 
Chi-Square test of independence (for 2×2 comparisons) or the exact binomial test (for 
comparing White to Black frequencies to the expected 2:1 distribution). Continuous data 
(e.g., LOS) were compared using nonparametric Wilcoxon two-sample tests. A Cox 
proportional hazards model was constructed to assess the risk of readmission over time 
between Black and White children. The proportionality assumption of the Cox model was 
examined and validated with a Kaplan-Meier survival curve. The Kaplan-Meier survival 
analysis with a log-rank test was then used to compare the probability of readmission in the 
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first year after index hospitalization by race. Multivariate logistic regression models were 
constructed to assess the influence of the following predictors on readmission status (yes 
versus no): age at first admission, gender, geographical region (West, Midwest, South, and 
Northeast), corticosteroid use, biologic agent use, TPN use, insurance payor (Medicaid, 
commercial, and other), and income. This was calculated for the total number of 
readmissions, readmission within 1 year, readmission after 1 year, and LOS. Similar 
multivariate logistic regression models were constructed to assess the IBD-related 
complications and procedures which occurred during the index hospitalization, and for any 
hospitalization.
For each set of analyses, we assumed a critical alpha of 0.05 and made Bonferroni 
corrections for multiple testing where appropriate. We expected that small effects would be 
magnified by our large study population and considered an effect size of >0.15 to be 
clinically meaningful. All statistical analyses were conducted using SAS 9.3 (by SAS 




Overall, agreement between data extracted from PHIS and data from NCH documentation 
was high. For race, corticosteroid usage, and TPN usage, the PHIS and NCH records agreed 
for over 99% and payor status percent agreement was about 94%.
Descriptive Statistics
The initial query included 26,381 total encounters and 11,190 distinct patients, with a final 
cohort of 1456 Black children and 2921 White children (Figure 1). We found no significant 
differences in either gender or geographical region between the Black and White cohorts. 
Compared with White children, Black children were slightly older at the first admission, 
were more likely to have Medicaid as their primary payor, and had a lower median 
neighborhood income. (Table 1)
LOS
Black children had slightly longer LOS (6.8±7.1 days, median=5 days) than White children 
(6.3±8.9 days, median=4 days) (p<0.001, d=0.07) although the effect size was small.
Percent of Early and Late Readmissions
Using the exactly binomial test, there was no significant difference in the percentage of 
Black vs. White children who had an early readmission (154 (11%) vs. 327 (11%), ns), 
however a larger percentage of Black children had a late readmission (410 (28%) vs. 677 
(23%), p=0.002). During the overall study period, Black children had a higher frequency of 
readmissions (1.4±2.6, median=0) than White children (0.9±1.9, median=0) (p<0.001, 
d=0.19). Black children also had a higher number of readmissions after 1 year compared to 
White children (3.1±3.2 vs. 2.4±2.4, <0.001, d=0.22).
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A Kaplan-Meier survival analysis with a log-rank test shows that the probability of being 
readmitted was essentially identical for Blacks and Whites during the first 100 days, and 
after 100 days White patients had a statistically lower probability of readmission (p=0.009). 
A Cox proportional hazards model shows that in the first year after index admission, Black 
children had a 16% increase in risk of readmission compared to White children (p=0.01). 
(Figure 2)
Medication Use
Regarding the inpatient medical treatment, we found that more Blacks received biologic 
agents during any hospitalization, during the index hospitalization and also during late 
readmissions. More Blacks received corticosteroids during late readmissions. (Table 2)
Predictors of Readmission
In a multivariate model, race was a significant predictor of readmission (OR=1.28 95% CI 
[1.09, 1.50], p=0.009). Predictive factors of overall readmission included corticosteroid 
usage (OR=1.53, 95% CI [1.32, 1.78], p<0.001) and TPN usage (OR=1.32, 95% CI [1.10, 
1.59], p=0.009) during the index hospitalization, and patients with “Other” insurance status 
(OR=1.62, 95% CI [1.38, 1.91], p<0.001). Predictive factors of early readmission included 
older age (OR=1.05 per year older, 95% CI [1.02–1.09], p=0.01) and TPN usage (OR=1.54, 
95% CI [1.18, 2.00], p=0.004) during index hospitalization. The predictive factors of late 
readmission are corticosteroids given during the index hospitalization (OR=1.38, 95% CI 
[1.16, 1.64], p=0.0009).
IBD-related Complications and Procedures
During the index hospitalization, there was no significant difference between Black and 
White children for procedures, however more Black patients had perianal disease (8.6% vs. 
5.8%, p=0.011) and anemia (34.2% vs. 25.4%, p<0.002). Among the most prevalent 
diagnosis and procedure groups during any hospitalization, there was a higher percentage of 
Black patients with perianal disease (14.6 vs. 8.3%, p<0.002), anemia (42.6% vs. 31.1%, 
p<0.002), vitamin D deficiency (2.3% vs. 0.9%, p=0.002), and who underwent perianal/
perineal procedures (8.5% vs. 5.0%, p<0.001), endoscopies (52.1% vs. 46.4%, p=0.004)), 
and received blood product transfusions (14.2% vs. 10.9%, p=0.023) than Whites. (Tables 3 
and 4). Even after controlling for gender, income, and type of insurance in multivariate 
regression models, race remained as a significant predictor of the above complications and 
procedures.
DISCUSSION
To date, few studies have investigated healthcare disparities in CD, and most existing 
studies have focused on adult populations.27, 29–31 Of the few studies investigating racial 
disparities in pediatric CD, most have either utilized smaller sample sizes,32 discussed 
disparities in IBD without distinction between CD and UC,33 focused only on UC,34 or 
examined sociodemographic factors other than race that might be associated with 
disparities.35, 36
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Using a large and diverse cohort extracted from the PHIS database, our study investigated 
evidence of racial disparities in the treatment and outcomes of hospitalized White and Black 
pediatric patients with CD. Our findings support that racial disparities exist among children 
and adolescents with CD, but to what degree this represents a healthcare disparity or a 
disparity due to genetic and/or environmentally determined differences in disease is still 
unknown. We found several statistically significant differences between races, including 
important outcomes such as hospital readmissions; however the effect sizes were small. This 
suggests that although one may not readily identify these racial differences at a practice 
level due to the small effect size, they may be important at the population level. The etiology 
of these racial differences must be understood in order to design practice level interventions 
that can reduce population level disparities. In our study, Black children had a 1.5 times 
higher frequency of readmissions compared to White children.
Our large, regionally diverse cohort also allowed for the detection of other less common 
events and adds valuable information to the sparse literature on pediatric IBD race 
disparities. Our study supports the findings noted by Schaefer et al, that race did not 
influence the risk of bowel surgery.37 However, we found that Black children were more 
likely to have anemia, vitamin D deficiency, endoscopic procedures, blood product 
transfusions and treatment with corticosteroids and biologic agents compared to White 
children.
Some of the observed differences in our study are likely attributable to intrinsic differences 
in disease between Blacks and Whites. For example, the increase in perianal procedures is 
likely secondary to the increased rate of perianal disease in Blacks.24, 38, 39 However, other 
differences may reflect disparities in care, although biologic differences can’t be excluded. 
For instance, while the increased usage of corticosteroids and biologic agents among Black 
children could suggest a more severe disease course that may be attributable to worse 
intrinsic disease in Black children, it is equally possible that Black patients were more ill at 
the time of hospital admissions secondary to delays in seeking care or impaired access to 
care, thus requiring more intensive therapy. This point may also be strengthened by the fact 
that Black children were slightly older at the first admission than White children, which 
could represent a subtle marker of diminished access to medical care or a delay in disease 
recognition from a community health level. Unfortunately, there are no validated measures 
in PHIS to address disease severity as a potential explanatory factor.
We found that Black children had a lower median income and were more likely to have 
Medicaid. Financial barriers to outpatient care and self-management, such as transportation, 
medication and nutrition needs, may have influenced the disparities seen in our study. In 
support of this hypothesis, a recently published study found that Black children with asthma 
were twice as likely to be readmitted as White children and this difference was partially 
explained by financial and social hardship.40
It has been noted in other chronic diseases that the role of biology in health disparities is 
often modest and there are many other factors which contribute to disparities in 
care.14–16, 40–42 Some of these factors include SES status, access to care, payor status, health 
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care system inefficiencies, health literacy, adherence, and provider biases. We suspect that 
this is also true in pediatric IBD.
The limitations of our study include that the results may not be generalizable to all pediatric 
centers, the PHIS database is not weighted for extrapolation to national estimates and 
misclassification errors can also occur since the data were obtained from an administrative 
database. The strengths of this study include that it is a large, regionally diverse population 
and we minimized confounding by severity by focusing on a hospitalized cohort which 
restricted the study population to patients with moderate/severe disease.
There are significant differences in hospital readmissions, medication usage and both 
medical and surgical complications of children with CD which are related to race. It is 
unclear whether this is due to disparities in care, or phenotypic variation in disease between 
racial groups, although both likely play a role. We propose that non-biologic factors are 
likely contributors to these differences and may include factors such as differences in 
adherence, access or treatment, and may be influenced by financial considerations. Thus, 
future investigations should examine frequency of follow up care, adherence, access to care, 
disease severity and distribution, medication treatment differences and provider bias. Further 
primary research endeavors and standardization of care are needed to ultimately improve 
healthcare delivery and minimize healthcare disparities among minorities.42, 43 Minimizing 
complications and cost of care would have a profound effect on quality of life and healthcare 
expenditures.
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Cohort Section Procedures and Exclusion Criteria (*not mutually exclusive categories).
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Time to first readmission, according to race, in children hospitalized with Crohn’s disease. 
The graph depicts the curves are very close together in time period [0, 100], after 100 days, 
it appears that White patients had slightly less probability of readmission (Kaplan-Meier 
analysis with Log-Rank test, p=0.009; Cox proportional hazards p=0.01).
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TABLE 1






Total 1456 (33) 2921 (67)
Gender
  Male 781 (54) 1545 (53) 1
  Female 673 (46) 1373 (47)
Age at 1st admission (years) 14.6±3.4 (median: 15.1) 14.1±3.7 (median: 14.7) <0.001
Region
  Midwest 381 (26) 765 (26) NA
  Northeast 267 (18) 536 (18)
  South 731 (50) 1465 (50)
  West 77 (5) 155 (5)
Payor2
  Commercial 378 (26) 1305 (45) <0.001
  Medicaid 626 (43) 462 (16)
  Other 406 (28) 1056 (36)
  Missing 46 (3) 98 (3)
Median neighborhood income (at 1st admission)3. $39,855±$15,764 (median: $36,423) $53,599±$21,155 (median: $49,763) <0.001
1




Based on 2010 United States Census Data compared to reported zip code
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TABLE 2







  Corticosteroid 1025 (70) 1977 (68) 0.81
  Biologic agent 473 (33) 642 (22) 0.001
  TPN 399 (27) 719 (25) 0.56
Index
  Corticosteroid 943 (65) 1786 (61) 0.23
  Biologic agent 278 (19) 405 (14) 0.001
  TPN 262 (18) 508 (17) 1
Early (<30 days)
  Corticosteroid 103 (7) 234 (8) 1
  Biologic agent 34 (2) 74 (3) 1
  TPN 36 (3) 95 (3) 1
Late (30 days-1yr)
  Corticosteroid 287 (20) 416 (14) 0.001
  Biologic agent 130 (9) 169 (6) 0.001
  TPN 89 (6) 149 (5) 1
1
Bonferroni corrected p value; TPN=total parenteral nutrition
TPN=total parenteral nutrition
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